Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Other Operating Expenses
Sonoma Pharmaceuticals Inc
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Operating Expenses
$1.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Operating Expenses
$2.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
43%
|
|
Pfizer Inc
NYSE:PFE
|
Other Operating Expenses
$2.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
15%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|